UPDATE: Alexion (ALXN) Peers Ramp
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall St set for lower open as Alphabet results reignite AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
Alexion Pharma's (ALXN) High Price Tag Has Many Questioning Roche Deal
July 15, 2013 10:47 AM EDTOn Friday, shares of Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) moved higher on reports it was being targeted by Roche. According to Reuters' sources, Roche is seeking billions in order to finance a $130/share bid. However, given the size, many are skeptical.
"Our EU pharma team is very skeptical about the likelihood of this deal... More



